Dementias pp 287-296 | Cite as

Economics of Dementia

  • C. Geroldi
  • A. Bianchetti
  • M. Trabucchi


In the last decade, direct and indirect costs of disease have been of great interest. Because of this we recognize that every choice in the health field is not an independent variable, but is strongly related to the economic resources available to a society and the historical context [1]. The great majority of studies, particularly those focused on chronic diseases, have suffered from important methodological problems. In studying the costs, one should not consider a disease to be an abstract entity, as if the clinical modifications were “in vitro” occurrences instead of a complex reality constituted by a puzzle of vital events. Therefore, a correct methodological basis is essential to compute the realistic costs of a chronic disease.


Nursing Home Indirect Cost Dementia Care Concurrent Disease National Health Care System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Levorato A, Rozzini R, Trabucchi M (1994) I costi della vecchiaia. Mulino, BolognaGoogle Scholar
  2. 2.
    Rocca WA, Hofman A, Brayne C, et al (1993) Frequency and distribution of Alzheimer’s disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol 30: 381–390CrossRefGoogle Scholar
  3. 3.
    National Institute on Aging (1993) Progress report on Alzheimer’s disease. NIH publication no 93-3409Google Scholar
  4. 4.
    Wimo A, Ljunggren G, Winblad B (1997) Costs of dementia and dementia care. Int J Geriatr Psychiatry 12: 841–856PubMedCrossRefGoogle Scholar
  5. 5.
    Geldmacher DS, Whitehouse PJ (1996) Evaluation of dementia. N Engl J Med 335: 330–336PubMedCrossRefGoogle Scholar
  6. 6.
    Bianchetti A, Trabucchi M (1994) L’impatto economico per 1a demenza: una ipotesi per l’Italia. Giorn Geront 42: 687–692Google Scholar
  7. 7.
    Trabucchi M, Govoni S, Bianchetti A (1995) Socio-economic aspects of Alzheimer’s disease treatment. In: Giacobini E, Becker R (eds) Alzheimer disease: therapeutic strategies. Birkhäuser, Boston, pp 459–463Google Scholar
  8. 8.
    Bianchetti A, Trabucchi M (1996) Dementia care. J Am Geriatr Soc 44: 1277–1278PubMedGoogle Scholar
  9. 9.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease. Neurology 34: 939–944PubMedCrossRefGoogle Scholar
  10. 10.
    Hughes CP, Berg L, Danziger WL, et al (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572PubMedCrossRefGoogle Scholar
  11. 11.
    Folstein MF, Folstein SE, McHug PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198PubMedCrossRefGoogle Scholar
  12. 12.
    Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffee MW (1963) The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185: 914–919PubMedCrossRefGoogle Scholar
  13. 13.
    Lawton MP, Brody E (1969) Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist 9: 179–186PubMedCrossRefGoogle Scholar
  14. 14.
    Yesavage JA, Brink TL, Rose TL, Andrey M (1983) Development and validation of a geriatric depression screening scale. J Psychiatr Res 17: 37–49CrossRefGoogle Scholar
  15. 15.
    Cohen-Mansfield J (1986) Agitated behavior in the elderly. II. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc 34: 722–727PubMedGoogle Scholar
  16. 16.
    Greenfield S, Blano DM, Elashoff RM (1987) Development and testing of a new index of comorbidity. Clin Res 35: 346AGoogle Scholar
  17. 17.
    Ostbye T, Crosse E (1994) Net economic costs of dementia in Canada. Can Med Assoc J 151: 1457–1464Google Scholar
  18. 18.
    Ernst RL, Hay JW (1994) The US economic and social costs of Alzheimer’s disease revisited. Am J Public Health 84: 1261–1264PubMedCrossRefGoogle Scholar
  19. 19.
    Stommel M, Collins CE, Given BA (1994) The costs of family contributions to the care of persons with dementia. Gerontologist 34: 199–205PubMedCrossRefGoogle Scholar
  20. 20.
    Max W (1993) The economic impact of Alzheimer’s disease. Neurology 43[Suppl 4]: S6–S10Google Scholar
  21. 21.
    Wimo A, Karlsson G, Sandman PO, Corder L, Winblad B (1997) Costs of illness due to dementia in Sweden. Int J Geriatr Psychiatry 12: 857–861PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • C. Geroldi
  • A. Bianchetti
  • M. Trabucchi

There are no affiliations available

Personalised recommendations